Different serotonin receptor agonists have distinct effects on sound-evoked responses in inferior colliculus.
The neuromodulator serotonin has a complex set of effects on the auditory responses of neurons within the inferior colliculus (IC), a midbrain auditory nucleus that integrates a wide range of inputs from auditory and nonauditory sources. To determine whether activation of different types of serotonin receptors is a source of the variability in serotonergic effects, four selective agonists of serotonin receptors in the serotonin (5-HT) 1 and 5-HT2 families were iontophoretically applied to IC neurons, which were monitored for changes in their responses to auditory stimuli. Different agonists had different effects on neural responses. The 5-HT1A agonist had mixed facilitatory and depressive effects, whereas 5-HT1B and 5-HT2C agonists were both largely facilitatory. Different agonists changed threshold and frequency tuning in ways that reflected their effects on spike count. When pairs of agonists were applied sequentially to the same neurons, selective agonists sometimes affected neurons in ways that were similar to serotonin, but not to other selective agonists tested. Different agonists also differentially affected groups of neurons classified by the shapes of their frequency-tuning curves, with serotonin and the 5-HT1 receptors affecting proportionally more non-V-type neurons relative to the other agonists tested. In all, evidence suggests that the diversity of serotonin receptor subtypes in the IC is likely to account for at least some of the variability of the effects of serotonin and that receptor subtypes fulfill specialized roles in auditory processing.
Hurley
Laura M
LM
Biology Department, Indiana University, 1001 E. Third St., Jordan Hall, Bloomington, IN 47405, USA. lhurley@indiana.edu
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology; D000161:Acoustic Stimulation; D000818:Animals; D002685:Chiroptera / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004566:Electrodes; D004594:Electrophysiology; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005110:Extracellular Space / Q000502:physiology; D018698:Glutamic Acid / Q000502:physiology; D007245:Inferior Colliculi / Q000187:drug effects*; D007478:Iontophoresis; D008297:Male; D011719:Pyrazines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D044282:Receptor, Serotonin, 5-HT1A / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D011719:Pyrazines; D011725:Pyridines; D011758:Pyrroles; D017366:Serotonin Receptor Agonists; D044282:Receptor, Serotonin, 5-HT1A; C065046:3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one; D012701:Serotonin; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; C014896:6-chloro-2-(1-piperazinyl)pyrazine; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin